Intercept Pharmaceuticals (NASDAQ:ICPT) reported its Q1 earnings results on Friday, May 6, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Intercept Pharmaceuticals beat estimated earnings by 35.56%, reporting an EPS of $-0.58 versus an estimate of $-0.9.
Revenue was up $6.92 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.13 which was followed by a 3.98% increase in the share price the next day.
Here's a look at Intercept Pharmaceuticals's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | -1.10 | -1.09 | -1.21 | -1.44 |
| EPS Actual | -1.23 | -0.63 | -0.33 | -1.22 |
| Revenue Estimate | 92.38M | 83.02M | 82.95M | 81.20M |
| Revenue Actual | 92.40M | 92.83M | 96.58M | 81.66M |
To track all earnings releases for Intercept Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
